Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.

Kane, R C; Cohen, M H; Broder, L E; Bull, M I; Creaven, P J; Fossieck, B E

Kane, R C; Cohen, M H; Broder, L E; Bull, M I; Creaven, P J; Fossieck, B E.

Cancer Chemother Rep ; 59(6): 1171-2, 1975.

Article in En | MEDLINE | ID: mdl-1222395

Subject(s)

Carcinoma, Bronchogenic/drug therapy; Carcinoma, Squamous Cell/drug therapy; Emetine/therapeutic use; Lung Neoplasms/drug therapy; Aged; Emetine/adverse effects; Humans; Male; Middle Aged

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Bronchogenic / Carcinoma, Squamous Cell / Emetine / Lung Neoplasms Limits: Aged / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Rep Year: 1975 Document type: Article

Search on Google

XML

PubMed Links